EcoDrugPlus

Adenosine A3 Receptor

Ensembl ID : ENSCAFG00020007993
Gene Symbol: ADORA3
3 Cross references
273 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSCAFG00020013741
Gene Symbol: ADA
3 Cross references
219 Possible Orthologues:

Adrenoceptor Alpha 1a

Ensembl ID : ENSCAFG00020012587
Gene Symbol: ADRA1A
3 Cross references
201 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSCAFG00020025610
Gene Symbol: ADRA1B
3 Cross references
265 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSCAFG00020001611
Gene Symbol: ADRA1D
3 Cross references
196 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSCAFG00020011952
Gene Symbol: ADRA2A
3 Cross references
227 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSCAFG00020019863
Gene Symbol: ADRA2B
3 Cross references
222 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSCAFG00020014633
Gene Symbol: ADRA2C
3 Cross references
227 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSCAFG00020012354
Gene Symbol: ADRB1
3 Cross references
163 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSCAFG00020023459
Gene Symbol: ADRB2
3 Cross references
265 Possible Orthologues:

Adrenoceptor Beta 3

Ensembl ID : ENSCAFG00020001758
Gene Symbol: ADRB3
3 Cross references
218 Possible Orthologues:

Advanced Glycosylation End-Product Specific Receptor

Ensembl ID : ENSCAFG00020001211
Gene Symbol: AGER
3 Cross references
170 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).